Skip to main content

Table 3 Multivariate analyses of factors related with PD in advanced NSCLC

From: Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

Variables β S.E. Wald df Sig. OR 95% CI for OR Score
Lower Upper
NMPs, ≥160 events/μL 1.321 0.604 4.779 1 0.029 3.748 1.147 12.253 4
PMPs, ≥80 events/μL 2.395 0.666 12.930 1 <0.0001 10.968 2.973 40.462 11
NLR, ≥3.3 1.595 0.613 6.779 1 0.009 4.929 1.483 16.375 5
Constant −3.607 0.767 22.123 1 0.000 0.027    
  1. NMPs neutrophil-derived microparticals, PMPs platelet-derived microparticles, NLR neutrophil-lymphocyte ratio, CYFRA-211 Cytokeratin 19 fragment